Syndecan-4 as Antithrombin Receptor of Human Neutrophils
- 1 September 2001
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 287 (1), 42-46
- https://doi.org/10.1006/bbrc.2001.5534
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Functions of Cell Surface Heparan Sulfate ProteoglycansAnnual Review of Biochemistry, 1999
- Glycosaminoglycan-binding microbial proteins in tissue adhesion and invasion: key events in microbial pathogenicityJournal of Medical Microbiology, 1999
- Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents.Journal of Clinical Investigation, 1998
- Multimerization of the Cytoplasmic Domain of Syndecan-4 Is Required for Its Ability to Activate Protein Kinase CJournal of Biological Chemistry, 1997
- Synthesis and Pharmacological Properties of a Close Analogue of an Antithrombotic Pentasaccharide (SR 90107A/ORG 31540)Journal of Medicinal Chemistry, 1997
- Membrane‐anchored proteoglycans of mouse macrophages: P388D1 cells express a syndecan‐4–like heparan sulfate proteoglycan and a distinct chondroitin sulfate formJournal of Cellular Physiology, 1993
- The coordinated regulation of heparan sulfate, syndecans and cell behaviorCurrent Opinion in Cell Biology, 1993
- Post-transcriptional regulation of syndecan-1 expression by cAMP in peritoneal macrophagesThe Journal of cell biology, 1993
- Specificity studies on the heparin lyases from Flavobacterium heparinumBiochemistry, 1993
- Structure-activity relationship in heparin: A synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activityBiochemical and Biophysical Research Communications, 1983